| Dec 05 | Dec 04 | Dec 03 | Jun 02 | Jun 01 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 772.37K | $ 1.07M | $ 3.50M | - | $ 1.79K |
| Operating Income | $ -8.86M | $ -13.99M | $ -3.71M | $ -21.04K | $ -148.75K |
| EBITDA | $ -8.80M | $ -13.96M | $ -3.66M | $ -20.15K | $ -143.72K |
| Net Income | $ -11.09M | $ -13.99M | $ -3.71M | $ -21.04K | $ -148.67K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 13.73M | $ 12.34M | $ 11.02M | $ 0.00 | $ 12.52K |
| Total Debt | $ 5.02M | $ 1.00M | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 4.92M | $ -254.01K | $ -2.95M | $ 0.00 | $ 0.00 |
| Total Liabilities | $ 9.64M | $ 5.35M | $ 2.96M | $ 2.63K | $ 1.52K |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -9.07M | $ -10.48M | $ -2.04M | $ 0.00 | $ -106.34K |
| Operating Cash Flow | $ -8.61M | $ -3.58M | $ -1.75M | $ 0.00 | $ -102.09K |
| Investing Cash Flow | |||||
| Financing Cash Flow |
AXM Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.